HomeInsightsStock Comparison

Balaxi Pharmaceuticals Ltd vs Zydus Lifesciences Ltd Stock Comparison

Balaxi Pharmaceuticals Ltd vs Zydus Lifesciences Ltd Stock Comparison

Last Updated on: May 22, 2025

Key Highlights

  • The Latest Trading Price of Balaxi Pharmaceuticals Ltd is ₹ 53.63 as of 22 May 09:34.
  • The P/E Ratio of Balaxi Pharmaceuticals Ltd changed from 12.1 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Zydus Lifesciences Ltd changed from 23.3 on March 2020 to 26.2 on March 2024 . This represents a CAGR of 2.37% over 5 years.
  • The Market Cap of Balaxi Pharmaceuticals Ltd changed from ₹ 74 crore on March 2020 to ₹ 2702 crore on March 2024 . This represents a CAGR of 105.35% over 5 yearsThe Market Cap of Zydus Lifesciences Ltd changed from ₹ 27344 crore on March 2020 to ₹ 101151 crore on March 2024 . This represents a CAGR of 29.90% over 5 years.
  • The revenue of Balaxi Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 77.23 crore. This represent the decline of -100% The revenue of Zydus Lifesciences Ltd for the Mar '25 is ₹ 6608 crore as compare to the Dec '24 revenue of ₹ 5326 crore. This represent the growth of 24.07%.
  • The ebitda of Balaxi Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 7.93 crore. This represent the decline of -100% The ebitda of Zydus Lifesciences Ltd for the Mar '25 is ₹ 1986 crore as compare to the Dec '24 ebitda of ₹ 1444 crore. This represent the growth of 37.49%.
  • The net profit of Balaxi Pharmaceuticals Ltd changed from ₹ -41.34 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Zydus Lifesciences Ltd changed from ₹ 1112 crore to ₹ 1248 crore over 8 quarters. This represents a CAGR of 5.97% .
  • The Dividend Payout of Balaxi Pharmaceuticals Ltd changed from 3.41 % on March 2022 to 0 % on March 2024 . This represents a CAGR of -100.00% over 3 yearsThe Dividend Payout of Zydus Lifesciences Ltd changed from 25.37 % on March 2020 to 8.77 % on March 2024 . This represents a CAGR of -19.14% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Balaxi Pharmaceuticals Ltd

  • Balaxi Ventures Limited was formerly incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942.
  • The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017.
  • The Company incorporated with a basic objective of running rubber and tea plantations and owns several plantations across South India. In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading.
  • The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.

About Zydus Lifesciences Ltd

  • Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products.
  • The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. Founded by the Late Promoter, Mr. Ramanbhai B. Patel, the Company was incorporated in May, 1995 and converted into a Public Limited Company in July, 1996.

Balaxi Pharmaceuticals Ltd News Hub

News

Balaxi Pharmaceuticals to convene board meeting

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 ...

Read more

03 Feb 2025 10:51

News

Balaxi Pharmaceuticals announces board meeting date

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 N...

Read more

30 Oct 2024 16:58

News

Balaxi Pharmaceuticals to conduct AGM

Balaxi Pharmaceuticals announced that the 81st Annual General Meeting(AGM) of the company ...

Read more

01 Aug 2024 12:52

News

Balaxi Pharmaceuticals to convene board meeting

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 A...

Read more

26 Jul 2024 10:45

News

Balaxi Pharma soars after expanding market presence in Angola & Latin America

In a regulatory filing made during market hours today, Balaxi Pharma stated that it has ha...

Read more

25 Jun 2024 12:14

News

Balaxi Pharmaceuticals to conduct board meeting

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 ...

Read more

24 May 2024 18:51

Zydus Lifesciences Ltd News Hub

News

Board of Zydus Lifesciences recommends final dividend

Zydus Lifesciences announced that the Board of Directors of the Company at its meeting hel...

Read more

20 May 2025 15:17

News

Zydus Lifes receives EIR for the Ambernath manufacturing facility

The inspection was conducted by the USFDA from 10 February to 14 February 2025 and conclud...

Read more

14 May 2025 14:16

News

Zydus Lifesciences receives EIR for its API manufacturing facility at Ambernath

Zydus Lifesciences has received the EIR report from the USFDA for the inspection conducted...

Read more

14 May 2025 15:28

News

Zydus Lifesciences schedules board meeting

Zydus Lifesciences will hold a meeting of the Board of Directors of the Company on 20 May ...

Read more

10 May 2025 11:06

News

Zydus Life gets US FDA nod for MS treatment drug Glatiramer Acetate

The Glatiramer Acetate Injection is an AP-rated substitutable generics of Copaxone, 20 mg/...

Read more

09 May 2025 09:21

News

Zydus Life gains after USFDA approval for Niacin Extended-Release tablets

The approved medication is indicated for the treatment of patients with primary hyperlipid...

Read more

30 Apr 2025 11:32

SWOT Analysis Of Zydus Lifesciences Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

SWOT Analysis Of Balaxi Pharmaceuticals Ltd

Strength

4

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Zydus Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Balaxi Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Balaxi Pharmaceuticals Ltd and Zydus Lifesciences Ltd

Which company has a larger market capitalization, Balaxi Pharmaceuticals Ltd or Zydus Lifesciences Ltd?

Market cap of Balaxi Pharmaceuticals Ltd is 291 Cr while Market cap of Zydus Lifesciences Ltd is 89,529 Cr

What are the key factors driving the stock performance of Balaxi Pharmaceuticals Ltd and Zydus Lifesciences Ltd?

The stock performance of Balaxi Pharmaceuticals Ltd and Zydus Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Balaxi Pharmaceuticals Ltd and Zydus Lifesciences Ltd?

As of May 22, 2025, the Balaxi Pharmaceuticals Ltd stock price is INR ₹52.83. On the other hand, Zydus Lifesciences Ltd stock price is INR ₹889.75.

How do dividend payouts of Balaxi Pharmaceuticals Ltd and Zydus Lifesciences Ltd compare?

To compare the dividend payouts of Balaxi Pharmaceuticals Ltd and Zydus Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions